Report Detail

Other Global Exosome Diagnostic and Therapeutics Market Professional Survey Report 2019

  • RnM3792404
  • |
  • 30 September, 2019
  • |
  • Global
  • |
  • 106 Pages
  • |
  • QYResearch
  • |
  • Other

Exosomes are cell-derived vesicles that are present in many and perhaps all eukaryotic fluids, including blood, urine, and cultured medium of cell cultures. A sub-type of exosomes, defined as matrix-bound nanovesicles (MBVs), was reported to be present in extracellular matrix (ECM) bioscaffolds (non-fluid). The reported diameter of exosomes is between 30 and 100 nm, which is larger than low-density lipoproteins (LDL) but much smaller than, for example, red blood cells. Exosomes are either released from the cell when multivesicular bodies fuse with the plasma membrane or released directly from the plasma membrane.
The exosome diagnostic and therapeutics market in North America is estimated to reach a high market valuation by end of 2027 and is projected to grow at a significant rate throughout the period of assessment.

The global Exosome Diagnostic and Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Exosome Diagnostic and Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Exosome Diagnostic and Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Exosome Diagnostic and Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Exosome Diagnostic and Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Thermo Fisher
NanoSomix
NX PHARMAGEN
Malvern
Capricor
Exosome
Exiqon
System Biosciences
Aegle
AMS

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Instrument
Software
Reagents and Kits

Segment by Application
Hospitals
Cancer Institutes
Diagnostic Centres
Others


Table of Contents

    Executive Summary

      1 Industry Overview of Exosome Diagnostic and Therapeutics

      • 1.1 Definition of Exosome Diagnostic and Therapeutics
      • 1.2 Exosome Diagnostic and Therapeutics Segment by Type
        • 1.2.1 Global Exosome Diagnostic and Therapeutics Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Instrument
        • 1.2.3 Software
        • 1.2.4 Reagents and Kits
      • 1.3 Exosome Diagnostic and Therapeutics Segment by Applications
        • 1.3.1 Global Exosome Diagnostic and Therapeutics Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Cancer Institutes
        • 1.3.4 Diagnostic Centres
        • 1.3.5 Others
      • 1.4 Global Exosome Diagnostic and Therapeutics Overall Market
        • 1.4.1 Global Exosome Diagnostic and Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Exosome Diagnostic and Therapeutics Production (2014-2025)
        • 1.4.3 North America Exosome Diagnostic and Therapeutics Status and Prospect (2014-2025)
        • 1.4.4 Europe Exosome Diagnostic and Therapeutics Status and Prospect (2014-2025)
        • 1.4.5 China Exosome Diagnostic and Therapeutics Status and Prospect (2014-2025)
        • 1.4.6 Japan Exosome Diagnostic and Therapeutics Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Exosome Diagnostic and Therapeutics Status and Prospect (2014-2025)
        • 1.4.8 India Exosome Diagnostic and Therapeutics Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Exosome Diagnostic and Therapeutics
      • 2.3 Manufacturing Process Analysis of Exosome Diagnostic and Therapeutics
      • 2.4 Industry Chain Structure of Exosome Diagnostic and Therapeutics

      3 Development and Manufacturing Plants Analysis of Exosome Diagnostic and Therapeutics

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Exosome Diagnostic and Therapeutics Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Exosome Diagnostic and Therapeutics
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Exosome Diagnostic and Therapeutics Production and Capacity Analysis
      • 4.2 Exosome Diagnostic and Therapeutics Revenue Analysis
      • 4.3 Exosome Diagnostic and Therapeutics Price Analysis
      • 4.4 Market Concentration Degree

      5 Exosome Diagnostic and Therapeutics Regional Market Analysis

      • 5.1 Exosome Diagnostic and Therapeutics Production by Regions
        • 5.1.1 Global Exosome Diagnostic and Therapeutics Production by Regions
        • 5.1.2 Global Exosome Diagnostic and Therapeutics Revenue by Regions
      • 5.2 Exosome Diagnostic and Therapeutics Consumption by Regions
      • 5.3 North America Exosome Diagnostic and Therapeutics Market Analysis
        • 5.3.1 North America Exosome Diagnostic and Therapeutics Production
        • 5.3.2 North America Exosome Diagnostic and Therapeutics Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Exosome Diagnostic and Therapeutics Import and Export
      • 5.4 Europe Exosome Diagnostic and Therapeutics Market Analysis
        • 5.4.1 Europe Exosome Diagnostic and Therapeutics Production
        • 5.4.2 Europe Exosome Diagnostic and Therapeutics Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Exosome Diagnostic and Therapeutics Import and Export
      • 5.5 China Exosome Diagnostic and Therapeutics Market Analysis
        • 5.5.1 China Exosome Diagnostic and Therapeutics Production
        • 5.5.2 China Exosome Diagnostic and Therapeutics Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Exosome Diagnostic and Therapeutics Import and Export
      • 5.6 Japan Exosome Diagnostic and Therapeutics Market Analysis
        • 5.6.1 Japan Exosome Diagnostic and Therapeutics Production
        • 5.6.2 Japan Exosome Diagnostic and Therapeutics Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Exosome Diagnostic and Therapeutics Import and Export
      • 5.7 Southeast Asia Exosome Diagnostic and Therapeutics Market Analysis
        • 5.7.1 Southeast Asia Exosome Diagnostic and Therapeutics Production
        • 5.7.2 Southeast Asia Exosome Diagnostic and Therapeutics Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Exosome Diagnostic and Therapeutics Import and Export
      • 5.8 India Exosome Diagnostic and Therapeutics Market Analysis
        • 5.8.1 India Exosome Diagnostic and Therapeutics Production
        • 5.8.2 India Exosome Diagnostic and Therapeutics Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Exosome Diagnostic and Therapeutics Import and Export

      6 Exosome Diagnostic and Therapeutics Segment Market Analysis (by Type)

      • 6.1 Global Exosome Diagnostic and Therapeutics Production by Type
      • 6.2 Global Exosome Diagnostic and Therapeutics Revenue by Type
      • 6.3 Exosome Diagnostic and Therapeutics Price by Type

      7 Exosome Diagnostic and Therapeutics Segment Market Analysis (by Application)

      • 7.1 Global Exosome Diagnostic and Therapeutics Consumption by Application
      • 7.2 Global Exosome Diagnostic and Therapeutics Consumption Market Share by Application (2014-2019)

      8 Exosome Diagnostic and Therapeutics Major Manufacturers Analysis

      • 8.1 Thermo Fisher
        • 8.1.1 Thermo Fisher Exosome Diagnostic and Therapeutics Production Sites and Area Served
        • 8.1.2 Thermo Fisher Product Introduction, Application and Specification
        • 8.1.3 Thermo Fisher Exosome Diagnostic and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 NanoSomix
        • 8.2.1 NanoSomix Exosome Diagnostic and Therapeutics Production Sites and Area Served
        • 8.2.2 NanoSomix Product Introduction, Application and Specification
        • 8.2.3 NanoSomix Exosome Diagnostic and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 NX PHARMAGEN
        • 8.3.1 NX PHARMAGEN Exosome Diagnostic and Therapeutics Production Sites and Area Served
        • 8.3.2 NX PHARMAGEN Product Introduction, Application and Specification
        • 8.3.3 NX PHARMAGEN Exosome Diagnostic and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Malvern
        • 8.4.1 Malvern Exosome Diagnostic and Therapeutics Production Sites and Area Served
        • 8.4.2 Malvern Product Introduction, Application and Specification
        • 8.4.3 Malvern Exosome Diagnostic and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Capricor
        • 8.5.1 Capricor Exosome Diagnostic and Therapeutics Production Sites and Area Served
        • 8.5.2 Capricor Product Introduction, Application and Specification
        • 8.5.3 Capricor Exosome Diagnostic and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Exosome
        • 8.6.1 Exosome Exosome Diagnostic and Therapeutics Production Sites and Area Served
        • 8.6.2 Exosome Product Introduction, Application and Specification
        • 8.6.3 Exosome Exosome Diagnostic and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Exiqon
        • 8.7.1 Exiqon Exosome Diagnostic and Therapeutics Production Sites and Area Served
        • 8.7.2 Exiqon Product Introduction, Application and Specification
        • 8.7.3 Exiqon Exosome Diagnostic and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 System Biosciences
        • 8.8.1 System Biosciences Exosome Diagnostic and Therapeutics Production Sites and Area Served
        • 8.8.2 System Biosciences Product Introduction, Application and Specification
        • 8.8.3 System Biosciences Exosome Diagnostic and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Aegle
        • 8.9.1 Aegle Exosome Diagnostic and Therapeutics Production Sites and Area Served
        • 8.9.2 Aegle Product Introduction, Application and Specification
        • 8.9.3 Aegle Exosome Diagnostic and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 AMS
        • 8.10.1 AMS Exosome Diagnostic and Therapeutics Production Sites and Area Served
        • 8.10.2 AMS Product Introduction, Application and Specification
        • 8.10.3 AMS Exosome Diagnostic and Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Exosome Diagnostic and Therapeutics Market

      • 9.1 Global Exosome Diagnostic and Therapeutics Market Trend Analysis
        • 9.1.1 Global Exosome Diagnostic and Therapeutics Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Exosome Diagnostic and Therapeutics Regional Market Trend
        • 9.2.1 North America Exosome Diagnostic and Therapeutics Forecast 2019-2025
        • 9.2.2 Europe Exosome Diagnostic and Therapeutics Forecast 2019-2025
        • 9.2.3 China Exosome Diagnostic and Therapeutics Forecast 2019-2025
        • 9.2.4 Japan Exosome Diagnostic and Therapeutics Forecast 2019-2025
        • 9.2.5 Southeast Asia Exosome Diagnostic and Therapeutics Forecast 2019-2025
        • 9.2.6 India Exosome Diagnostic and Therapeutics Forecast 2019-2025
      • 9.3 Exosome Diagnostic and Therapeutics Market Trend (Product Type)
      • 9.4 Exosome Diagnostic and Therapeutics Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Exosome Diagnostic and Therapeutics Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Exosome Diagnostic and Therapeutics. Industry analysis & Market Report on Exosome Diagnostic and Therapeutics is a syndicated market report, published as Global Exosome Diagnostic and Therapeutics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Exosome Diagnostic and Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,758.00
        4,137.00
        5,516.00
        3,220.00
        4,830.00
        6,440.00
        544,670.00
        817,005.00
        1,089,340.00
        291,830.00
        437,745.00
        583,660.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report